Shakeri-Zadeh Ali, Bulte Jeff W M
The Russell H. Morgan Department of Radiology and Radiological Science, Division of MR Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Cellular Imaging Section and Vascular Biology Program, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Nat Rev Bioeng. 2025 Mar;3(3):245-260. doi: 10.1038/s44222-024-00257-3. Epub 2024 Nov 7.
Magnetic nanoparticles, including those formed of superparamagnetic iron oxides (SPIOs), are employed in various magnetic imaging and therapeutic techniques. In vivo imaging techniques based on the detection of magnetic nanoparticles inside the body include magnetic resonance imaging (MRI), magnetic particle imaging (MPI), magneto-motive ultrasonography (MMUS) and magneto-photoacoustic imaging (MPAI). Preclinical data indicate that the conditions required to heat up magnetic nanoparticles, including energy considerations, particle modifications, localization and exposure time, can be dynamically modulated during a single treatment procedure by monitoring imaging data acquired from the same magnetic nanoparticles. This Review explores the potential use of magnetic-nanoparticle-mediated imaging techniques combined with magnetic fluid hyperthermia (MFH) to selectively and precisely heat tumour locations while avoiding damage to surrounding healthy tissue. Imaging-guided MFH could provide individualized treatment plans based on information about the biodistribution of magnetic nanoparticles within the tumour and adjacent organs, as well as the volumetric distribution of the thermal dose. Requirements for the clinical translation of MFH-enabled magnetic imaging techniques are also discussed - the development of magnetic nanoparticle formulations with a favourable biosafety profile, optimal magnetic heating properties and maximal magnetic imaging signals; and the integration of magnetic imaging and heating hardware into a single platform.
磁性纳米颗粒,包括由超顺磁性氧化铁(SPIO)形成的那些,被用于各种磁成像和治疗技术中。基于检测体内磁性纳米颗粒的体内成像技术包括磁共振成像(MRI)、磁粒子成像(MPI)、磁动力超声成像(MMUS)和磁光声成像(MPAI)。临床前数据表明,加热磁性纳米颗粒所需的条件,包括能量考量、颗粒修饰、定位和暴露时间,可在单个治疗过程中通过监测从相同磁性纳米颗粒获取的成像数据进行动态调节。本综述探讨了磁性纳米颗粒介导的成像技术与磁流体热疗(MFH)相结合的潜在用途,以选择性地、精确地加热肿瘤部位,同时避免对周围健康组织造成损伤。成像引导的MFH可根据磁性纳米颗粒在肿瘤和相邻器官内的生物分布信息以及热剂量的体积分布提供个性化治疗方案。还讨论了支持MFH的磁成像技术临床转化的要求——开发具有良好生物安全性、最佳磁热性能和最大磁成像信号的磁性纳米颗粒制剂;以及将磁成像和加热硬件集成到单个平台中。